HIFU in the treatment of Hypersplenism

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNC-08000281

Enrollment

Unknown

Registered

2008-12-21

Start date

2008-10-16

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersplenism

Interventions

Case series:HIFU treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypersplenism patiens

Exclusion criteria

Exclusion criteria: 1. WBC <2*10^9 or Plt<20*10^9; 2. PTA<60%; 3. Active digestive tract hemorrhage; 4. Uncontrolled infection; 5. Severe liver and kidney dysfunction; 6. Without safe HIFU cannel.

Design outcomes

Primary

Measure	Time frame
IL-2/11, Tufstin, PV/SPV;	—

Secondary

Measure	Time frame
C3/C4;RBC/WBC/PLT;IgM/A/E/G/D, T/B/NK cell;	—

Countries

China

Contacts

Public ContactMei Zhechuan

The Second Affiliated Hospital, Chongqing Medical University

meizhechuan@21cn.com+86 023 63726690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026